
Sign up to save your podcasts
Or


In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.
By American College of Cardiology4.4
3737 ratings
In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.

323 Listeners

500 Listeners

166 Listeners

40 Listeners

902 Listeners

20 Listeners

3 Listeners

3,375 Listeners

137 Listeners

1,151 Listeners

62 Listeners

367 Listeners

16 Listeners

433 Listeners

36 Listeners